Abu Freha Naim, Leibovici Weissman Yaara, Fich Alexander, Barnes Kedar Inbal, Halpern Marisa, Sztarkier Ignacio, Behar Doron M, Arbib Sneh Orly, Vilkin Alex, Baris Hagit N, Gingold Rachel, Lejbkowicz Flavio, Niv Yaron, Goldberg Yael, Levi Zohar
Department of Gastroenterology, Soroka Medical Center, Beer-Sheva, Israel.
Department of Gastroenterology, Beilinson Medical Center, Petah Tikva, Israel.
Fam Cancer. 2018 Jan;17(1):79-86. doi: 10.1007/s10689-017-0009-7.
We assessed the molecular characteristics and the frequency of mutations in mismatch-repair genes among Bedouin patients with colorectal cancer (CRC) in Israel. Bedouin patients with a diagnosis of CRC at a major hospital in the southern part of Israel were deemed eligible for this study. The primary screening method was immunohistochemical staining for mismatch-repair proteins (MLH1, MSH2, MSH6, and PMS2). For subjects with abnormal immunohistochemical staining, we performed microsatellite instability (MSI) analyses, and for tumors with a loss of MLH1 expression we also performed BRAF testing. In MSI high cases we searched further for germline mutations. Of the 24 patients enrolled, four subjects (16.7%) had MSI high tumors: one subject was found to harbor a biallelic PMS2 mutation, one subject had Lynch syndrome (LS) with MSH6 mutation and two subjects had a loss of MLH1/PMS2 proteins/BRAF /normal MLH1 sequence. Ten patients (41.7%) were younger than 50 at the time of diagnosis and none had first degree relatives with CRC. In conclusion, in this cohort of 24 consecutive Arab Bedouins with CRC, one patient was found to harbor a constitutional mismatch repair deficiency, one patient had LS with MSH6 mutation, and two patients had unresolved loss of MLH1/PMS2 proteins/BRAF phenotype.
我们评估了以色列贝都因族结直肠癌(CRC)患者错配修复基因的分子特征和突变频率。在以色列南部一家主要医院被诊断为CRC的贝都因族患者被认为符合本研究条件。主要筛查方法是对错配修复蛋白(MLH1、MSH2、MSH6和PMS2)进行免疫组织化学染色。对于免疫组织化学染色异常的受试者,我们进行了微卫星不稳定性(MSI)分析,对于MLH1表达缺失的肿瘤,我们还进行了BRAF检测。在MSI高的病例中,我们进一步寻找种系突变。在纳入的24例患者中,4例(16.7%)肿瘤MSI高:1例发现携带双等位基因PMS2突变,1例患有林奇综合征(LS)伴MSH6突变,2例MLH1/PMS2蛋白/BRAF/正常MLH1序列缺失。10例患者(41.7%)诊断时年龄小于50岁,且均无患CRC的一级亲属。总之,在这24例连续的患有CRC的阿拉伯贝都因人群体中,1例发现存在遗传性错配修复缺陷,1例患有伴MSH6突变的LS,2例存在未解决的MLH1/PMS2蛋白/BRAF表型缺失。